Patients with chronic kidney disease have a high risk of adverse kidney and cardiovascular outcomes Farxiga is a medication used to treat chronic kidney disease The effect of dapagliflozin in patients with chronic kidney disease, with or without type 2 diab.
Nudes | womenofcurves
Approved by the fda for the treatment of ckd, farxiga offers renal protection and enhances kidney function in patients with this condition.
Farxiga (dapagliflozin) is a diabetes medication that’s approved to treat chronic kidney disease (ckd)
But how does farxiga work, and is it safe for everyone? Farxiga (dapagliflozin) is an sglt2 inhibitor used for type 2 diabetes (t2d), heart failure (hfref/hfpef), and chronic kidney disease (ckd) Patients often ask whether 5 mg or 10 mg is the “right” dose It depends on your condition, goals (glucose, heart, or kidney protection), and how you tolerate the medication
This guide explains how clinicians choose between 5 mg and. Farxiga was given once daily in addition to standard of care.
